Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients
2006
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis
2007
Long-term Safety and Efficacy of 50 mg of Etanercept Twice Weekly in Patients With Psoriasis
2007
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
NF-κB signaling in inflammation
2017 Standout
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
2019
Psoriasis
2009 Standout
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system
2003
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)
2005
Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Chronic Pain Grade Scale (CPGS), Short Form‐36 Bodily Pain Scale (SF‐36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)
2011 Standout
Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems
2004
Hidradenitis suppurativa: A comprehensive review
2009 Standout
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group
2009
Pathogenesis and clinical features of psoriasis
2007 Standout
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
2012
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
2008 Standout
Reliability and validity of the Italian version of the Chronic Pain Grade questionnaire in patients with musculoskeletal disorders
2006
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate
2001
Neuropathic Arthropathy of the Foot with and without Superimposed Osteomyelitis: MR Imaging Characteristics
2006
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)
2005
Juvenile idiopathic arthritis
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept
2005
Diagnosis and treatment of psoriatic arthritis
2004
Abatacept in the treatment of patients with psoriatic arthritis: Results of a six‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II trial
2010
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept
2008
Etanercept and efalizumab for the treatment of psoriasis: a systematic review
2006
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
2005 Standout
Psoriasis
2021 Standout
Patient-assessed health in ankylosing spondylitis: a structured review
2005
The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases
2013
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
2017
National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening
2008
Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts
2015
Bone Contusion Patterns of the Knee at MR Imaging: Footprint of the Mechanism of Injury
2000
Clinical management of psoriatic arthritis
2018
MR imaging of the diabetic foot
2004
From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation
2004
Psoriasis
2015 Standout
Psoriasis: emerging therapeutic strategies
2005
Anti–tumor necrosis factor α blockade in the treatment of juvenile spondylarthropathy
2005
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Crohn's disease
2016 Standout
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review
2014
Ankylosing spondylitis
2007 Standout
Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
2012
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
2005
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
2003
Managing comorbid disease in patients with psoriasis
2010
Revisiting the gut–joint axis: links between gut inflammation and spondyloarthritis
2020
TNFα blockade in human diseases: An overview of efficacy and safety
2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis
2005
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial
2005
Development and preselection of criteria for short term improvement after anti-TNFα treatment in ankylosing spondylitis
2004
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
2005
Mechanism-based Pattern Approach to Classification of Complex Injuries of the Knee Depicted at MR Imaging
2000
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
2008
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
2020 StandoutNobel
Pirfenidone in idiopathic pulmonary fibrosis
2009 Standout
Functional Specialization of Interleukin-17 Family Members
2011 Standout
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
2010 Standout
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
2009
Hidradenitis suppurativa
2020 Standout
Guidelines of care for the management of psoriasis and psoriatic arthritis
2008
10 Years of GWAS Discovery: Biology, Function, and Translation
2017 Standout
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called 'efficacy and safety' trials: a survey of power considerations
2008
Ulcerative colitis
2020 Standout
Adalimumab reduces spinal symptoms in active ankylosing spondylitis: Clinical and magnetic resonance imaging results of a fifty‐two–week open‐label trial
2006
Radiography in the assessment of musculoskeletal conditions
2003
Idiopathic pulmonary fibrosis
2011 Standout
Quality criteria were proposed for measurement properties of health status questionnaires
2006 Standout
Psoriasis
2016
The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder
2006
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α
2002
Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab
2005
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
2009 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Anterior Cruciate Ligament and Intercondylar Notch in the Coronal Oblique Plane: Anatomy Complemented by Magnetic Resonance Imaging in Cruciate Ligament–Intact Knees
1999
Pedal Abscesses in Patients Suspected of Having Pedal Osteomyelitis: Analysis with MR Imaging
2002
Management of Crohn's Disease in Adults
2009 Standout
Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double‐blind, placebo‐controlled magnetic resonance imaging study
2006
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
2013
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
The Long-term Consequence of Anterior Cruciate Ligament and Meniscus Injuries
2007 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment.
2007
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
Immunology of Psoriasis
2014 Standout
Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.
2007
FoxP3+T regulatory cells in Rheumatoid arthritis and the imbalance of the Treg/TH17 cytokine axis
2014
MRI analysis of single‐, double‐, and triple‐bundle anterior cruciate ligament grafts
2013 StandoutNobel
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
TNF‐mediated inflammatory disease
2007 Standout
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of David Salonen being referenced
Effect of adalimumab on joint disease: features of patients with psoriatic arthritis detected by magnetic resonance imaging
2009
Posterolateral aspect of the knee: improved MR imaging with a coronal oblique technique.
1996
ROTATOR CUFF EVALUATION: IMAGING AND DIAGNOSIS
1997
Plantar compartments of the foot: MR appearance in cadavers and diabetic patients.
1995
Complete dislocation of the knee: spectrum of associated soft-tissue injuries depicted by MR imaging.
1995
Spondyloarthritis research consortium of canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis
2005
Radiological assessment in psoriatic arthritis
1998
Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double‐blind, placebo‐controlled study
2007
Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis
2005
Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
2004
Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
2005
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
2006
Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized Computed Tomography Scoring System
2017
Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
2009
Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis.
2001
Colonic aphthous ulcers in pseudomembranous colitis.
1989